Kineta Announces Participation in the H.C. Wainwright 24th Annual Global Healthcare Conference
Seattle, WA — (September 12, 2022) Kineta, Inc. (“Kineta” or the “Company”), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today th ...